Matinas BioPharma Holdings (MTNB) EBT Margin (2015 - 2023)
Matinas BioPharma Holdings (MTNB) recorded EBT Margin of -2093.25% in FY2023, down 1321.92 percentage points from -771.33% in FY2022.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) EBT Margin (2015 - 2023) Analysis & Trends
Starting with FY2015, Matinas BioPharma Holdings' EBT Margin history includes 8 years.
- Annual EBT Margin has a five-year change of +10137.69 percentage points (FY2018 to FY2023).
- Annual EBT Margin has ranged from -74954.55% in FY2021 to -771.33% in FY2022 over the past five years.
- Per Business Quant data, MTNB's EBT Margin was -771.33% in FY2022 (+74183.22 pp), -74954.55% in FY2021 (-59666.16 pp), -15288.38% in FY2020 (+5779.00 pp) and -21067.38% in FY2019 (-8836.45 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Matinas BioPharma Holdings | 508,224.03 | -12.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -509.67% |
| Dec 31, 2022 | -515.52% |
| Sep 30, 2022 | -513.83% |
| Jun 30, 2022 | -557.38% |
| Mar 31, 2021 | -19,059.52% |
| Dec 31, 2020 | -10,382.22% |
| Sep 30, 2020 | -5,848.30% |
| Jun 30, 2019 | -5,033.49% |
| Mar 31, 2019 | 0.00% |
| Jun 30, 2018 | -3,791.13% |
| Mar 31, 2018 | -13,764.74% |
| Dec 31, 2017 | -10,311.72% |
| Sep 30, 2017 | -7,589.85% |
| Jun 30, 2017 | -8,854.73% |
| Mar 31, 2017 | -29,976.78% |
| Sep 30, 2015 | -3,606.48% |
| Jun 30, 2015 | -3,119.21% |
| Mar 31, 2015 | -4,456.62% |
API Access
Matinas BioPharma Holdings EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();